631 related articles for article (PubMed ID: 30634002)
1. Proteomic characterization of outer membrane vesicles from gut mucosa-derived fusobacterium nucleatum.
Liu J; Hsieh CL; Gelincik O; Devolder B; Sei S; Zhang S; Lipkin SM; Chang YF
J Proteomics; 2019 Mar; 195():125-137. PubMed ID: 30634002
[TBL] [Abstract][Full Text] [Related]
2. Quantitative Proteomic Analysis of Outer Membrane Vesicles from Fusobacterium nucleatum Cultivated in the Mimic Cancer Environment.
Zhang X; Wang Y; Fan R; Zhang L; Li Z; Zhang Y; Zheng W; Wang L; Liu B; Quan C
Microbiol Spectr; 2023 Aug; 11(4):e0039423. PubMed ID: 37341631
[TBL] [Abstract][Full Text] [Related]
3.
Engevik MA; Danhof HA; Ruan W; Engevik AC; Chang-Graham AL; Engevik KA; Shi Z; Zhao Y; Brand CK; Krystofiak ES; Venable S; Liu X; Hirschi KD; Hyser JM; Spinler JK; Britton RA; Versalovic J
mBio; 2021 Mar; 12(2):. PubMed ID: 33653893
[TBL] [Abstract][Full Text] [Related]
4.
Hussan H; Clinton SK; Roberts K; Bailey MT
World J Gastroenterol; 2017 Dec; 23(48):8626-8650. PubMed ID: 29358871
[TBL] [Abstract][Full Text] [Related]
5. Association of Fusobacterium nucleatum with immunity and molecular alterations in colorectal cancer.
Nosho K; Sukawa Y; Adachi Y; Ito M; Mitsuhashi K; Kurihara H; Kanno S; Yamamoto I; Ishigami K; Igarashi H; Maruyama R; Imai K; Yamamoto H; Shinomura Y
World J Gastroenterol; 2016 Jan; 22(2):557-66. PubMed ID: 26811607
[TBL] [Abstract][Full Text] [Related]
6. The Role of
Pignatelli P; Nuccio F; Piattelli A; Curia MC
Microorganisms; 2023 Sep; 11(9):. PubMed ID: 37764202
[TBL] [Abstract][Full Text] [Related]
7. Aspirin Modulation of the Colorectal Cancer-Associated Microbe Fusobacterium nucleatum.
Brennan CA; Nakatsu G; Gallini Comeau CA; Drew DA; Glickman JN; Schoen RE; Chan AT; Garrett WS
mBio; 2021 Apr; 12(2):. PubMed ID: 33824205
[TBL] [Abstract][Full Text] [Related]
8. Siglec-7 Mediates Immunomodulation by Colorectal Cancer-Associated
Lamprinaki D; Garcia-Vello P; Marchetti R; Hellmich C; McCord KA; Bowles KM; Macauley MS; Silipo A; De Castro C; Crocker PR; Juge N
Front Immunol; 2021; 12():744184. PubMed ID: 34659241
[No Abstract] [Full Text] [Related]
9.
Martin-Gallausiaux C; Malabirade A; Habier J; Wilmes P
Front Immunol; 2020; 11():583644. PubMed ID: 33408714
[TBL] [Abstract][Full Text] [Related]
10. The ways Fusobacterium nucleatum translocate to breast tissue and contribute to breast cancer development.
Guo X; Yu K; Huang R
Mol Oral Microbiol; 2024 Feb; 39(1):1-11. PubMed ID: 38171827
[TBL] [Abstract][Full Text] [Related]
11. Fusobacterium nucleatum: a commensal-turned pathogen.
Han YW
Curr Opin Microbiol; 2015 Feb; 23():141-7. PubMed ID: 25576662
[TBL] [Abstract][Full Text] [Related]
12.
Casasanta MA; Yoo CC; Udayasuryan B; Sanders BE; Umaña A; Zhang Y; Peng H; Duncan AJ; Wang Y; Li L; Verbridge SS; Slade DJ
Sci Signal; 2020 Jul; 13(641):. PubMed ID: 32694172
[No Abstract] [Full Text] [Related]
13. Berberine may rescue Fusobacterium nucleatum-induced colorectal tumorigenesis by modulating the tumor microenvironment.
Yu YN; Yu TC; Zhao HJ; Sun TT; Chen HM; Chen HY; An HF; Weng YR; Yu J; Li M; Qin WX; Ma X; Shen N; Hong J; Fang JY
Oncotarget; 2015 Oct; 6(31):32013-26. PubMed ID: 26397137
[TBL] [Abstract][Full Text] [Related]
14. Fusobacterium nucleatum induces oxaliplatin resistance by inhibiting ferroptosis through E-cadherin/β-catenin/GPX4 axis in colorectal cancer.
Li B; Wei Z; Wang Z; Xu F; Yang J; Lin B; Chen Y; Wenren H; Wu L; Guo X; Liu Y; Wei Y
Free Radic Biol Med; 2024 Aug; 220():125-138. PubMed ID: 38657754
[TBL] [Abstract][Full Text] [Related]
15. Invasive potential of gut mucosa-derived Fusobacterium nucleatum positively correlates with IBD status of the host.
Strauss J; Kaplan GG; Beck PL; Rioux K; Panaccione R; Devinney R; Lynch T; Allen-Vercoe E
Inflamm Bowel Dis; 2011 Sep; 17(9):1971-8. PubMed ID: 21830275
[TBL] [Abstract][Full Text] [Related]
16. Delivery of short chain fatty acid butyrate to overcome Fusobacterium nucleatum-induced chemoresistance.
Chen L; Zhao R; Kang Z; Cao Z; Liu N; Shen J; Wang C; Pan F; Zhou X; Liu Z; Yang Y; Chen Q
J Control Release; 2023 Nov; 363():43-56. PubMed ID: 37734673
[TBL] [Abstract][Full Text] [Related]
17. Proteomic profiling of Gram-negative bacterial outer membrane vesicles: Current perspectives.
Lee J; Kim OY; Gho YS
Proteomics Clin Appl; 2016 Oct; 10(9-10):897-909. PubMed ID: 27480505
[TBL] [Abstract][Full Text] [Related]
18.
Wu QL; Fang XT; Wan XX; Ding QY; Zhang YJ; Ji L; Lou YL; Li X
World J Gastroenterol; 2024 Apr; 30(14):2018-2037. PubMed ID: 38681125
[TBL] [Abstract][Full Text] [Related]
19. Fusobacterium nucleatum: an emerging bug in colorectal tumorigenesis.
Bashir A; Miskeen AY; Bhat A; Fazili KM; Ganai BA
Eur J Cancer Prev; 2015 Sep; 24(5):373-85. PubMed ID: 25569450
[TBL] [Abstract][Full Text] [Related]
20.
Liu C; Zhang H; Li T; Jiang Z; Yuan Y; Chen X
Infect Immun; 2023 Aug; 91(8):e0010223. PubMed ID: 37404144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
